Diabetes drugs appear to lower colorectal cancer risk
Glucagon-like receptor agonists (GLP-1 RAs), a class of type 2 diabetes drug treatments, appear to also reduce the risk of colorectal cancer (CRC) researchers reported on Dec. 7,… read more.
Glucagon-like receptor agonists (GLP-1 RAs), a class of type 2 diabetes drug treatments, appear to also reduce the risk of colorectal cancer (CRC) researchers reported on Dec. 7,… read more.
Cancer that spreads to the brain from another part of the body such as lung or breast is called a metastatic brain tumor. As metastatic brain tumors grow,… read more.
Breakthrough COVID-19 infection is more prevalent among vaccinated cancer patients than in the general population, and the results are more dangerous, researchers reported on April 8, 2022 in… read more.